Filter by: patients
Home > Community Treatment Reports and Side Effects > Hydromorphone Treatment Report
What is Hydromorphone?

Hydromorphone (trade names Palladone IR, Palladone SR, Dilaudid and numerous others) is a potent centrally-acting analgesic drug of the opioid class; it is a derivative of morphine, specifically a hydrogenated ketone thereof -- therefore a semi-synthetic drug and both an opiate and a true narcotic.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Pain 70 21 Efficacy_major Efficacy_moderate Efficacy_slight
Chronic pain 30 4 Efficacy_major Efficacy_moderate
Fibromyalgia 21 5 Efficacy_major Efficacy_moderate
Breakthrough pain 10 2 Efficacy_moderate
Pain in lower back 8 2 Efficacy_major Efficacy_slight
Other 7 3 Efficacy_major Efficacy_moderate

See all 135 patients currently taking Hydromorphone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 13
Mild
 12
None
 14

Commonly reported side effects, conditions, and hospitalizations associated with Hydromorphone

Constipation 5
Drowsiness 4
Nausea 3
Dizziness 2
Nausea and vomiting 2
Fatigue 2
See all 27 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Hydromorphone. See all 44 dosages ►

  1mg as needed 2mg as needed 8mg as needed 4mg as needed 4 mg daily 6 mg daily 8 mg daily 12 mg daily 16 mg daily 24 mg daily
  5 Number of Patients: 5 20 Number of Patients: 20 7 Number of Patients: 7 20 Number of Patients: 20 12 Number of Patients: 12 9 Number of Patients: 9 7 Number of Patients: 7 7 Number of Patients: 7 6 Number of Patients: 6 7 Number of Patients: 7  

Reported Stop Reasons

Why Patients Stopped Taking Hydromorphone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 11   Side effects too severe: 31%
Course of treatment ended 9   Course of treatment ended: 25%
Other 8   Other: 22%
Doctor's advice 8   Doctor's advice: 22%
Did not seem to work 5   Did not seem to work: 14%
Change in health plan coverage 1   Change in health plan coverage: 3%
Not indicated 1   Not indicated: 3%

See all 35 patients who’ve stopped taking Hydromorphone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Hydromorphone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Hydromorphone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Hydromorphone

Always
 26 63%
Usually
 11 27%
Sometimes
 2 5%
Never
 2 5%

Burden

Difficulty being on treatment

Burden of Hydromorphone

Very
 5 12%
Somewhat
 1 2%
A little
 8 20%
Not at all
 27 66%

Cost

Paid out of pocket

Cost of Hydromorphone

$200+
 0 0%
$100-199
 4 17%
$50-99
 2 9%
$25-49
 0 0%
< $25
 17 74%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.